Register entryShortage reportedRepackager / relabeller
pharmaand GmbH
- Registered sites
- 1
- Drug products
- 5
- Live patents
- 27
- Countries
- 1
- Base
- Austria
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
LabellingPackagingRelabellingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| pharmaand GmbH Zweigniederlassung Scheibbs | ScheibbsAustria | Labelling, Packaging, Relabelling, Repackaging | 3039485501 |
Alert
Products in shortage
2| Drug | Presentation | Availability |
|---|---|---|
| Peginterferon alfa-2a Injection | Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1) | Unavailable |
| Peginterferon alfa-2a Injection | Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4) | Available |
Exclusivity
Patents
27Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| RUBRACA | RUCAPARIB CAMSYLATE | Aug 2027 |
| RUBRACA | RUCAPARIB CAMSYLATE | Feb 2031 |
| RUBRACA | RUCAPARIB CAMSYLATE | Aug 2031 |
| RUBRACA | RUCAPARIB CAMSYLATE | Aug 2035 |
Catalogue
Marketed products
5Showing 5 of 5.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Pegasys | peginterferon alfa-2a | INJECTION, SOLUTION | BLA |
| Pegasys | peginterferon alfa-2a | INJECTION, SOLUTION | BLA |
| Rubraca | rucaparib | TABLET, FILM COATED | NDA |
| Rubraca | rucaparib | TABLET, FILM COATED | NDA |
| Rubraca | rucaparib | TABLET, FILM COATED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.